Ben Yong
Insider CIK 1967669 · CRBP Director · BBOT Chief Med & Dev Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BBOT BridgeBio Oncology Therape | F Tax w/h | 2026-10-01 | 2026-10-05 | 1,047 | $3.94 | $4.1K | 43,529 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | S Sale | 2026-09-14 | 2026-09-15 | 2,000 | $7.84 | $15.7K | 9,383 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | S Sale | 2026-09-14 | 2026-09-15 | 2,000 | $7.84 | $15.7K | 9,383 | SEC↗ |
| BBOT BridgeBio Oncology Therape | F Tax w/h | 2026-07-01 | 2026-07-06 | 1,047 | $7.80 | $8.2K | 44,576 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award deriv | 2026-05-19 | 2026-05-21 | 12,300 | — | $0 | 12,300 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award | 2026-05-19 | 2026-05-21 | 3,800 | — | $0 | 11,383 | SEC↗ |
| BBOT BridgeBio Oncology Therape | F Tax w/h | 2026-04-01 | 2026-05-05 | 1,047 | $9.03 | $9.5K | 45,623 | SEC↗ |
| BBOT BridgeBio Oncology Therape | A Award deriv | 2026-03-10 | 2026-03-12 | 210,000 | — | $0 | 210,000 | SEC↗ |
| BBOT BridgeBio Oncology Therape | A Award | 2026-03-10 | 2026-03-12 | 46,670 | — | $0 | 46,670 | SEC↗ |
| BBOT BridgeBio Oncology Therape | A Award deriv | 2025-08-26 | 2025-08-28 | 357,177 | — | $0 | 357,177 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award deriv | 2025-05-30 | 2025-06-02 | 16,000 | — | $0 | 16,000 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award | 2025-05-30 | 2025-06-02 | 4,800 | — | $0 | 7,583 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award | 2024-05-30 | 2024-06-03 | 2,783 | — | $0 | 2,783 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award deriv | 2024-05-16 | 2024-05-20 | 2,783 | — | $0 | 2,783 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award deriv | 2023-05-18 | 2023-05-22 | 5,300 | — | $0 | 5,300 | SEC↗ |
| CRBP Corbus Pharmaceuticals Hol | A Award deriv | 2023-03-06 | 2023-03-07 | 5,307 | — | $0 | 5,307 | SEC↗ |